Press Releases

MIDWEST BIORESEARCH ADDS LABORATORY INFORMATION
MANAGEMENT SYSTEM
Skokie, IL (March 10, 2008) - Midwest BioResearch LLC (MBR), a contract research organization focused on drug disposition and toxicology, implemented a Thermo Scientific Watson Laboratory Information Management System™ into their laboratory. Watson LIMS 7.3 is ideally suited for the needs of pharmacokinetic and bioanalytical laboratories, and complies with GLP regulations and 21 CFR Part 11 guidance.

> Read the Full Press Release

MIDWEST BIORESEARCH HIRES FORMER FDA INVESTIGATOR JAMES PLUCINSKI TO GUIDE CLIENT QUALITY ASSURANCE
Skokie, Ill. (January 17, 2008) -- Midwest BioResearch LLC (MBR), a contract research organization focused on drug disposition and toxicology, announced the addition of James Plucinski as its new Quality Assurance Manager. Plucinski, a former investigator with the Food and Drug Administration (FDA), will manage MBR's quality assurance program.

> Read the Full Press Release

MIDWEST BIORESEARCH EXPANSION FUELS MOVE TO NEW FACILITY
Drug Disposition and Toxicology Contract Research Organization Rides Outsourcing Boom
Skokie, Ill. (June 19, 2007) -- Midwest BioResearch, LLC (MBR) today announced that rapid company growth has necessitated a move to a new facility:  ironically, the former Pfizer/Pharmacia/Searle site where many of MBR’s colleagues once worked.  Fueling the company’s expansion is a marked increase in demand for its drug disposition and toxicology services at all stages of drug research and development, a sign of the overall good health of the outsourcing industry.  

> Read the Full Press Release

MIDWEST BIORESEARCH INTRODUCES INDUSTRY’S FIRST SCREEN THAT FULLY PREDICTS THE GLP REGULATORY AMES TEST
Screen Offers Cost-Effective and Rapid Solution for Drug Lead Optimization
Skokie, Ill. (March 19, 2007) -- Midwest BioResearch, LLC (MBR), an outsourced drug disposition and toxicology contract services provider, today announces the introduction of a novel microAmes screen that fully predicts the GLP regulatory Ames test (Salmonella/E. coli Mammalian Microsome Reverse Mutation Assay).  The screen is accurate, rapid, flexible and cost-effective, making it an essential consideration for anyone interested in efficient drug discovery and development through smarter decision making during lead optimization.

> Read the Full Press Release

MIDWEST BIORESEARCH ADDS TWO MORE SEASONED BIG PHARMA INDUSTRY PROFESSIONALS TO STAFF
Adds Two More Seasoned Big Pharma Industry Professionals
Evanston, Ill. (June 28, 2006) -- Midwest BioResearch, LLC (MBR), founded by former scientists, managers and directors from major pharmaceutical companies to provide outsourced drug disposition and toxicology services, today announced the appointment of Paul Donovan as its Controller and Peggy Tsatsos as manager in the company’s Analytical Operations group.  The company now has a staff of more than 30 with proven experience in drug discovery and development.